Atea Pharmaceuticals Announces Achievement of AT-527 Development Milestone Under License ...

Retrieved on: 2021-06-16 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

Atea Pharmaceuticals Announces Achievement of AT-527 Development Milestone Under License .... View article details on hiswai:

Excerpt

Under the license agreement, Roche and Atea are jointly developing AT-527 for the treatment of COVID-19. Atea retains rights to commercialize ...

Article found on: www.globenewswire.com